By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Calithera Biosciences, Inc. 

7000 Shoreline Court
Suite 255
South San Francisco  California  94080  U.S.A.
Phone: n/a Fax: n/a



Company News
Calithera Biosciences, Inc. (CALA) Presents Novel Pharmacodynamic Assay Data Confirming Glutaminase Inhibition In Tumor Biopsy Samples From Patients Treated With CB-839 12/11/2014 7:33:04 AM
Calithera Biosciences, Inc. (CALA) Gains Exclusive, Worldwide License To Mars Symbioscience's Arginase Inhibitors 12/9/2014 10:41:51 AM
Calithera Biosciences, Inc. (CALA) Presents Preclinical Study Findings For CB-839 At The 56th American Society of Hematology Annual Meeting 12/9/2014 10:36:13 AM
Calithera Biosciences, Inc. (CALA) Appoints H. Ward Wolff To Board Of Directors 12/5/2014 10:54:38 AM
Calithera Biosciences, Inc. (CALA) Reports Financial Results For The Fiscal Quarter Ended September 30, 2014 11/14/2014 7:47:50 AM
SSF's Calithera Biosciences, Inc. (CALA) Prices IPO At $10 A Share, Below The Range 10/2/2014 8:20:10 AM
South San Francisco's Calithera Biosciences, Inc. Seeks $80 Million In IPO 8/26/2014 6:24:25 AM
Calithera Biosciences, Inc. Presents Pharmacodynamic Data On CB-839 At The 2014 American Association for Cancer Research Annual Meeting 4/8/2014 6:47:50 AM
Calithera Biosciences, Inc. To Present Data On CB-839 At The American Association for Cancer Research Annual Meeting 2014 4/1/2014 6:44:24 AM
Calithera Biosciences, Inc. Appoints William D. Waddill Chief Financial Officer 3/25/2014 7:10:50 AM